{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
United-Guardian, Inc.
United-Guardian, Inc. Stock Plummets to New 52-Week Low of $6.50
United-Guardian, Inc., a microcap specialty chemicals firm, has reached a new 52-week low, reflecting a significant decline in stock performance over the past year. The company reported a drop in net profit and sales, while maintaining a strong return on equity and a conservative financial structure.
United-Guardian, Inc. Stock Plummets to New 52-Week Low of $6.95
United-Guardian, Inc., a microcap specialty chemicals firm, has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company reported a notable drop in net profit and sales, while maintaining a high dividend yield and low leverage, indicating ongoing challenges.
United-Guardian, Inc. Stock Plummets to New 52-Week Low of $7.17
United-Guardian, Inc., a microcap specialty chemicals company, has reached a 52-week low, reflecting a challenging year with a 19.89% stock price decline. The company reported a net profit decrease of 37.66% and a 19.95% drop in net sales, despite maintaining a 7.10% dividend yield and a 22.07% return on equity.
United-Guardian, Inc. Stock Plummets to New 52-Week Low of $7.25
United-Guardian, Inc., a microcap specialty chemicals firm, has reached a new 52-week low, reflecting a 1-year performance drop of 17.88%. The company reported a net profit decline of 37.66% and a 19.95% decrease in net sales, despite a commitment to shareholder returns through a 7.10% dividend yield.
United-Guardian, Inc. Stock Hits New 52-Week Low at $7.42
United-Guardian, Inc., a microcap specialty chemicals firm, has experienced a challenging year, marked by a significant decline in net profit and sales. Despite a robust dividend yield and low debt levels, the company's stock performance has lagged behind broader market trends, reflecting ongoing financial difficulties.
United-Guardian, Inc. Stock Plummets to New 52-Week Low of $7.50
United-Guardian, Inc., a microcap specialty chemicals firm, has hit a new 52-week low, reflecting a tough year with a significant stock decline. The company has a market cap of USD 39 million, a P/E ratio of 13.00, and a dividend yield of 7.10%, despite recent drops in profit and sales.
United-Guardian, Inc. Stock Hits New 52-Week Low at $7.60
United-Guardian, Inc., a microcap specialty chemicals firm, has reached a new 52-week low, reflecting a 1-year performance drop of 13.32%. The company reported a net profit decline of 37.66% and a 19.95% decrease in net sales, despite a strong dividend yield and low debt-to-equity ratio.
United-Guardian, Inc. Stock Hits New 52-Week Low at $7.64
United-Guardian, Inc., a microcap specialty chemicals firm, recently hit a 52-week low, reflecting a one-year performance decline. The company reported a significant drop in net profit and sales, despite maintaining a low debt-to-equity ratio and a notable return on equity, indicating ongoing operational challenges.
United-Guardian, Inc. Stock Hits New 52-Week Low at $7.66
United-Guardian, Inc., a microcap specialty chemicals firm, has hit a new 52-week low, reflecting a one-year return significantly below the S&P 500. The company has a market cap of USD 39 million, a P/E ratio of 13.00, and a dividend yield of 7.10%, despite declining financial results.
Is United-Guardian, Inc. technically bullish or bearish?
As of September 12, 2025, United-Guardian, Inc. has shifted to a bearish trend with weak strength, indicated by bearish daily moving averages and a monthly MACD, while significantly underperforming the S&P 500 with year-to-date and one-year returns of -17.05% and -45.42%, respectively.
Is United-Guardian, Inc. overvalued or undervalued?
As of March 21, 2025, United-Guardian, Inc. is considered very attractive due to its undervalued P/E ratio of 13, strong growth potential indicated by a PEG ratio of 0.60, impressive ROCE of 119.03%, and a high dividend yield of 8.45%, despite a disappointing 1Y return of -45.42% compared to the S&P 500's 17.14%.
United-Guardian, Inc. Reports Declining Financial Results Amid Operational Challenges in August 2025
United-Guardian, Inc. reported its financial results for the quarter ending June 2025, revealing a decline in net profit to USD 1.16 million and net sales of USD 5.32 million. Operating cash flow also fell to USD 2.12 million, indicating challenges in profitability and operational efficiency.
Is United-Guardian, Inc. overvalued or undervalued?
As of February 5, 2025, United-Guardian, Inc. is considered a very attractive investment due to its undervalued status with a P/E ratio of 13, a favorable PEG ratio of 0.60, a high dividend yield of 8.45%, and competitive metrics compared to peers, despite recent underperformance relative to the S&P 500.
Is United-Guardian, Inc. technically bullish or bearish?
As of June 13, 2025, United-Guardian, Inc. shows a bearish trend with mixed signals from indicators, as the weekly MACD is mildly bullish while the monthly MACD and moving averages are bearish, suggesting a weak technical position.
Who are in the management team of United-Guardian, Inc.?
As of March 2022, the management team of United-Guardian, Inc. includes Mr. Kenneth Globus as Chairman, President, CEO, and General Counsel, along with independent directors Mr. Andrew Boccone, Mr. Arthur Dresner, Mr. Lawrence Maietta, and Mr. S. Ari Papoulias.
What does United-Guardian, Inc. do?
United-Guardian, Inc. is a micro-cap company that manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, and specialty industrial products. As of March 2025, it reported net sales of $2 million and a net profit of $1 million, with a market cap of $37.53 million.
How big is United-Guardian, Inc.?
As of Jun 18, United-Guardian, Inc. has a market capitalization of 37.53 million, with net sales of 11.41 million and a net profit of 2.89 million over the latest four quarters.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
